Nicotinell Rapid Relief

Nicotine, the active ingredient in Nicotinell Rapid Relief, is a nicotine replacement therapy presented as an oromucosal product for oromucosal use. It helps adult smokers reduce withdrawal symptoms and cravings during a quit attempt, supporting the transition away from combustible tobacco.

GNH USA supplies Nicotinell Rapid Relief as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies, hospitals and clinics worldwide, ensuring consistent quality and regulatory compliance.

Nicotinell Rapid Relief, a nicotine replacement therapy, is used to aid smoking cessation by delivering controlled nicotine to lessen withdrawal. - Smoking cessation: helps adult smokers quit by reducing cravings and withdrawal symptoms. - Tobacco dependence: provides a regulated nicotine dose to manage dependence during quit attempts. - Relapse prevention: supports individuals who have recently stopped smoking to maintain abstinence.

Common and serious adverse reactions have been reported with oromucosal nicotine products.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Throat irritation: discomfort or scratchy feeling in the throat. - Nausea: transient feeling of queasiness. - Headache: mild to moderate headache. - Dizziness: brief light‑headed sensation. - Hiccups: occasional involuntary diaphragm spasms.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or itching indicating hypersensitivity. - Chest pain: unexpected discomfort that may require medical evaluation. - Irregular heartbeat: palpitations or arrhythmia. - Severe mouth ulceration: persistent ulcer that does not heal. - Anaphylaxis: rare life‑threatening systemic allergic response.

Before using Nicotinell Rapid Relief, consider the following precautions to ensure safe and effective use. - Assess nicotine dependence: evaluate the level of smoking and prior quit attempts. - Avoid use in non‑smokers: product is intended only for individuals who smoke. - Do not combine with other nicotine products: concurrent use may lead to nicotine overdose. - Monitor cardiovascular status: patients with heart disease should use under medical supervision. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture.

Nicotinell Rapid Relief may interact with certain medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Concurrent use of other nicotine replacement therapies: risk of nicotine toxicity. - Use with monoamine oxidase inhibitors: may increase hypertensive response.

Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors (e.g., methoxsalen): can alter nicotine metabolism. - Alcohol consumption: may enhance nicotine cravings and side effects. - Certain antidepressants (e.g., bupropion): combined use may increase seizure risk.